TrialDrugs & aging2013

Immunogenicity and safety of a quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) administered to adults aged 56 Years and older: results of an open-label, randomized, controlled trial.

Ghassan Dbaibo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.